Home/Pipeline/Infectious Disease mAb Platform

Infectious Disease mAb Platform

Infectious Diseases (Pandemic Preparedness)

DiscoveryActive

Key Facts

Indication
Infectious Diseases (Pandemic Preparedness)
Phase
Discovery
Status
Active
Company

About mAIbe

mAIbe S.r.l. is a private, pre-revenue biotechnology company headquartered in Milan, Italy, with a registered office in Rome. The company is building a proprietary AI/ML platform that integrates physics-based models with generative AI to accelerate and optimize the discovery and development of monoclonal antibody therapies for infectious diseases. Focused on a significant unmet medical need, mAIbe aims to transform mAb R&D by drastically reducing development time and cost, thereby making advanced biologic treatments more accessible. The company is in the pre-clinical/platform development stage and is actively building scientific partnerships to advance its technology.

View full company profile

Therapeutic Areas